| E1068 |
Nab-Paclitaxel
|
Nab-Paclitaxel is a novel solvent-free paclitaxel in which the binding ratio of paclitaxel to human albumin is approximately 1:9. It is an anti-microtubule drug that promotes microtubule aggregation in tubulin dimers and inhibits microtubule depolymerization to stabilize the microtubule system. Solutions are unstable and should be fresh-prepared.
|
-
Mol Ther, 2025, 33(12):6160-6177
-
J Nanobiotechnology, 2025, 23(1):691
-
Br J Cancer, 2025, 10.1038/s41416-025-03185-0
|
|
| S1148 |
Docetaxel
|
Docetaxel, an analog of paclitaxel, is an inhibitor of depolymerisation of microtubules by binding to stabilized microtubules.
|
-
NPJ Precis Oncol, 2026, 10.1038/s41698-026-01400-6
-
Cells, 2026, 15(4)383
-
Cancer Discov, 2025, 10.1158/2159-8290.CD-25-0629
|
|
| S2775 |
Nocodazole
|
Nocodazole is a rapidly-reversible inhibitor of microtubule polymerization, also inhibits Abl, Abl(E255K) and Abl(T315I) with IC50 of 0.21 μM, 0.53 μM and 0.64 μM in cell-free assays, respectively. Nocodazole induces apoptosis.
|
-
Adv Mater, 2025, e17493.
-
Nat Commun, 2025, 16(1):7898
-
EMBO J, 2025, 44(22):6556-6597
|
|
| S0328 |
MMAF (Monomethylauristatin F)
|
MMAF (Monomethylauristatin F) is a synthetic antineoplastic agent and a potent inhibitor of tubulin polymerization. MMAF (Monomethylauristatin F) is applied as a cytotoxic component of antibody-drug conjugates (ADCs) such as vorsetuzumab mafodotin, ABT-414 and SGN-CD19A.
|
-
Cancer Cell, 2021, S1535-6108(21)00659-0
|
|
| S1150 |
Paclitaxel
|
Paclitaxel is a microtubule polymer stabilizer with IC50 of 0.1 pM in human endothelial cells.Paclitaxel can cause both mitotic arrest and apoptotic cell death. Paclitaxel also induces autophagy.
|
-
Cancer Research, March 01, 2021, 1413-1425
-
International Journal of Molecular Medicine, February 01, 2019, 1866-1878
-
Therapeutic Advances in Medical Oncology, December 11, 2024, 17588359241303302
|
|
| S1241 |
Vincristine (Leurocristine) Sulfate
|
Vincristine sulfate is an inhibitor of polymerization of microtubules by binding to tubulin with IC50 of 32 μM in a cell-free assay. Vincristine sulfate induces apoptosis.
|
-
International Journal of Molecular Sciences, October 25, 2023, 15571
-
eLife, November 19, 2019, e50036
-
Oncotarget, November 05, 2019, 6403-6417
|
|
| S7721 |
MMAE (Monomethyl auristatin E)
|
MMAE (Monomethyl auristatin E) is a synthetic antineoplastic agent. It is also a microtubule-disrupting agent .
|
-
Front Immunol, 2024, 15:1393485
-
Leuk Lymphoma, 2023, 1-11.
-
Br J Haematol, 2022, 10.1111/bjh.18341
|
|
| S9555 |
Vincristine
|
Vincristine (Leurocristine, NSC-67574, 22-Oxovincaleukoblastine) is a natural alkaloid isolated from the plant Vinca rosea Linn. with anti-tumor activity. Vincristine inhibits microtubule formation in mitotic spindle and binds to microtubule with Ki of 85 nM.
|
-
Nat Commun, 2025, 16(1):4133
-
Cell Rep Med, 2025, S2666-3791(25)00102-8
-
Proc Natl Acad Sci U S A, 2025, 122(28):e2507203122
|
|
| S7787 |
Docetaxel Trihydrate
|
Docetaxel (RP56976, NSC 628503), an analog of paclitaxel, is an inhibitor of depolymerisation of microtubules by binding to stabilized microtubules.
|
-
iScience, 2024, 27(10):110862
-
PLoS Biol, 2023, 21(4):e3002038
-
Mol Cancer, 2022, 21(1):150
|
|
| S4269 |
Vinorelbine Ditartrate (KW-2307)
|
Vinorelbine ditartrate is a semi-synthetic vinca alkaloid, and inhibits mitosis through interaction with tubulin. Vinorelbine Tartrate exhibits anti-tumor activities via inducing the mitotic apoptosis, autophagy and inflammation.
|
-
Cancer Sci, 2026, 117(2):418-428
-
RSC Adv, 2026, 16(20):18359-18373
-
Commun Biol, 2025, 8(1):152
|
|